04:32 AM EST, 12/02/2025 (MT Newswires) -- Belite Bio ( BLTE ) said Monday it has priced an underwritten public offering of about 2.3 million American depositary shares at $154 each.

The company said it has also granted underwriters a 30-day option to purchase up to 340,909 additional depositary shares.

The company said it expects gross proceeds of about $350 million from the offering, which is expected to close about Wednesday.

The company said it plans to use net proceeds of the offering for general corporate purposes.